Skip to main navigation Skip to search Skip to main content

Comparative Pharmacokinetics of Epoetin Alfa in Cancer Subjects Receiving Cyclic Chemotherapy and in Healthy Subjects After Subcutaneous Administration of Epoetin Alfa 150 IU/kg 3 Times Weekly or 40,000 IU Per Week for 6 Weeks

Grants and Contracts Details

StatusFinished
Effective start/end date3/1/02 → 9/30/03

Funding

  • R W Johnson Pharmaceutical Research Institute: $79,955.00